Patient Perspectives on AI-Supported Communication in Health Care
-
By
-
Jenna Congdon
-
October 20, 2026
By
Jenna Congdon
October 20, 2026
The first at-home subcutaneous treatment for thyroid eye disease met its primary end point in 1 of 2 phase 3 trials.
by Mouj Hijazi
October 16, 2026
The accelerated approval adds an immunotherapy option for patients with MSI-H/dMMR stage II/III disease.
by Mouj Hijazi
October 19, 2026
A laboratory- and device-based model outperformed the current 6-status system in predicting short-term mortality among heart transplant candidates.
October 14, 2026